Covered recipient · General Payments record
CHRISTOPHER DAGHER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$48,198.77
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $19,705.84 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca UK Limited | $19,025.84 | 23 |
| EISAI INC. | $680.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $1,062.50 | 01/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093952721 | CMS |
| AstraZeneca UK Limited | $566.66 | 01/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093992048 | CMS |
| AstraZeneca UK Limited | $566.67 | 01/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094007303 | CMS |
| AstraZeneca UK Limited | $850.00 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093894451 | CMS |
| AstraZeneca UK Limited | $850.00 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094047394 | CMS |
| AstraZeneca UK Limited | $1,133.34 | 03/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093934110 | CMS |
| AstraZeneca UK Limited | $850.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093995602 | CMS |
| AstraZeneca UK Limited | $850.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094014595 | CMS |
| AstraZeneca UK Limited | $850.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093941812 | CMS |
| AstraZeneca UK Limited | $1,133.33 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093892275 | CMS |
| AstraZeneca UK Limited | $1,133.33 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093974056 | CMS |
| AstraZeneca UK Limited | $680.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093975885 | CMS |
| AstraZeneca UK Limited | $680.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093984141 | CMS |
| AstraZeneca UK Limited | $680.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094050533 | CMS |
| AstraZeneca UK Limited | $680.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093941452 | CMS |
| AstraZeneca UK Limited | $680.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093949204 | CMS |
| AstraZeneca UK Limited | $680.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094005060 | CMS |
| AstraZeneca UK Limited | $1,416.67 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093961369 | CMS |
| AstraZeneca UK Limited | $566.67 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093899477 | CMS |
| AstraZeneca UK Limited | $566.67 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093982507 | CMS |
| AstraZeneca UK Limited | $850.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093904219 | CMS |
| AstraZeneca UK Limited | $850.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093977013 | CMS |
| AstraZeneca UK Limited | $850.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093987305 | CMS |
| Eisai Inc. | $680.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110736763 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.